Ernexa Therapeutics Warrants ERNAW Slide Over 20 as Key Support Nears STVN Q1 2026 Earnings EPS Surpasses Expectations Amid Operational Discipline SDGR Q1 2026 Earnings EPS Misses Estimates Amid Strategic Platform Progress Stock Rises 695